These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17120158)

  • 1. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas.
    Kohshi K; Yamamoto H; Nakahara A; Katoh T; Takagi M
    J Neurooncol; 2007 May; 82(3):297-303. PubMed ID: 17120158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
    Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W
    J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.
    Combs SE; Bischof M; Welzel T; Hof H; Oertel S; Debus J; Schulz-Ertner D
    J Neurooncol; 2008 Sep; 89(2):205-10. PubMed ID: 18461281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
    Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.
    Combs SE; Thilmann C; Edler L; Debus J; Schulz-Ertner D
    J Clin Oncol; 2005 Dec; 23(34):8863-9. PubMed ID: 16314646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas.
    Shi W; Palmer JD; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Bar-Ad V; Judy K; Farrell C; Simone N; Liu H; Dicker AP; Lawrence YR
    J Neurooncol; 2016 May; 127(3):535-9. PubMed ID: 26821711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma.
    Landy H; Markoe A; Potter P; Lasalle G; Marini A; Savaraj N; Reis I; Heros D; Wangpaichitr M; Feun L
    J Neurooncol; 2004; 67(1-2):215-20. PubMed ID: 15072470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.
    Ogawa K; Yoshii Y; Inoue O; Toita T; Saito A; Kakinohana Y; Adachi G; Iraha S; Tamaki W; Sugimoto K; Hyodo A; Murayama S
    Br J Cancer; 2006 Oct; 95(7):862-8. PubMed ID: 16953239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
    Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
    Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.
    Kondziolka D; Flickinger JC; Bissonette DJ; Bozik M; Lunsford LD
    Neurosurgery; 1997 Oct; 41(4):776-83; discussion 783-5. PubMed ID: 9316038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.
    Wuthrick EJ; Curran WJ; Camphausen K; Lin A; Glass J; Evans J; Andrews DW; Axelrod R; Shi W; Werner-Wasik M; Haacke EM; Hillman GG; Dicker AP
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):369-75. PubMed ID: 25104067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionated stereotactic radiotherapy boost and weekly paclitaxel in malignant gliomas clinical and pharmacokinetics results.
    Ashamalla H; Zaki B; Mokhtar B; Lewis L; Lavaf A; Nasr H; Colella F; Dosik D; Krishnamurthy M; Saad N; Guriguis A
    Technol Cancer Res Treat; 2007 Jun; 6(3):169-76. PubMed ID: 17535024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastoma.
    Gregucci F; Di Guglielmo FC; Surgo A; Carbonara R; Laera L; Ciliberti MP; Gentile MA; Calbi R; Caliandro M; Sasso N; Davi' V; Bonaparte I; Fanelli V; Giraldi D; Tortora R; Internò V; Giuliani F; Surico G; Signorelli F; Lombardi G; Fiorentino A
    Strahlenther Onkol; 2024 Sep; 200(9):751-759. PubMed ID: 37987802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
    Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas.
    Gregucci F; Surgo A; Carbonara R; Laera L; Ciliberti MP; Gentile MA; Caliandro M; Sasso N; Bonaparte I; Fanelli V; Tortora R; Paulicelli E; Surico G; Lombardi G; Signorelli F; Fiorentino A
    J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.
    Patel M; Siddiqui F; Jin JY; Mikkelsen T; Rosenblum M; Movsas B; Ryu S
    J Neurooncol; 2009 Apr; 92(2):185-91. PubMed ID: 19066727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.
    Kim DH; Schultheiss TE; Radany EH; Badie B; Pezner RD
    J Neurooncol; 2013 Oct; 115(1):37-43. PubMed ID: 23813230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas.
    Schwer AL; Damek DM; Kavanagh BD; Gaspar LE; Lillehei K; Stuhr K; Chen C
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):993-1001. PubMed ID: 17967517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery.
    Choi SW; Cho KR; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI
    J Neurooncol; 2019 Dec; 145(3):571-579. PubMed ID: 31705245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiosurgery for recurrent gliomas.
    Chamberlain MC; Barba D; Kormanik P; Shea WM
    Cancer; 1994 Aug; 74(4):1342-7. PubMed ID: 8055458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.